Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

Conditions: Colorectal Cancer Metastatic Interventions: Drug: Cetuximab; Drug: Trifluridine/Tipiracil Sponsors: Wangxia LV Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials